comparemela.com
Home
Live Updates
Pharmacodynamic Assessments - Breaking News
Pages:
Latest Breaking News On - Pharmacodynamic assessments - Page 1 : comparemela.com
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis
These 2 randomized clinical trials compare the efficacy and safety of 2 doses of the autotaxin inhibitor ziritaxestat vs placebo in patients with idiopathic pul
Eteläuomen läi
United states
Los angeles
Vicore pharma
Devpro biopharma
Astrazeneca daiichi sankyo
Redx pharma
Tobym maher
Shionogi co ltd
Care center network
Janssen pharmaceuticals
Kinevant sciences
Bristol myers squibb
Puretech health
Gilead sciences
Boehringer ingelheim
vimarsana © 2020. All Rights Reserved.